DCTY1102注射液为国际上首款靶向HLA-A*11:01基因型、KRAS G12D突变的TCR-T细胞治疗产品,适应症为晚期、结直肠癌等恶性实体肿瘤。此产品获批IND是鼎成肽源的里程碑事件。鼎成肽源将全力推动产品的快速转化,服务社会,造福患者。 TCR-T类细胞药物的适用人群与HLA基因型密切相关,人类白细胞抗原(HLA)系统是免疫系统...
HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated Basic information More.. Product Name: HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) Monomer Protein, Human, MHC (His & Avi), Biotinylated Synonyms: HLA-A*11:01&B2M&KRAS G12V (VVGAVGVGK) ...
Biotinylated Human HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus. It contains Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M) and VVVGAVGVGK peptide.[Accession | AAV53343.1(HLA-A*11:01)&P61769(B2M)&VVV...
分子别名(Synonyms) K-Ras 2;C-K-RAS;KRAS;MHC表达区间及表达系统(Source) Human HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Tetramer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus, tetramer is assembled by biotinylated monomer and streptavidin. It contains Gly...
HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi) 化学名:HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi) 英語化学名:HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein, Human, MHC (His & Avi) MOL FileMo...
HLA-A*11:01限制性乙型肝炎病毒(HBV)肽用于鉴别HBV特异性CD8+ T细胞的用途.pdf,本发明涉及肽及其鉴别和结合对HBV感染的肝细胞具有特异性的T细胞的能力。在本发明的第一方面,提供了包含选自由以下项组成的组的氨基酸序列的肽:STLPETAVVRR、STLPETAVVR、STLPETTVVRR、STLPET
结核杆菌,胞内 DNA 受体,cGAS,自噬,巨噬细胞(ID 号:1173)HLA-A*11:01 限制性结核分枝杆菌 CD8+ T 细胞表位的筛选与鉴定刘苏东1 ,董海平 2 ,王娟娟 1 ,温茜 1 ,何健淳 1 ,杨晓帆 1 ,马骊 11. 南方医科大学生物技术学院分子免疫学研究所 2. 广州市胸科医院 研究背景 :近年多重耐药肺结核(MDR-TB)...
IX001 TCR-T注射液 上海镔铁 生物科技 有限责任公司 基因型为HLA-A*11:01,肿瘤抗原KRAS G12V表达为阳性的晚期胰腺癌 1
αβtcr 的作用是识别和结合体内细胞的hla分子中呈递的肽。一般来讲,除非它由特定hla分子呈递,否则tcr无法识别并结合肽,并且除非它呈递特异性肽,否则tcr无法识别hla分子。隐匿特异性tcr的t细胞将靶向在细胞上的特定hla分子(即肽-hla复合物)中呈递特异性肽的细胞,并且这是基于t细胞的免疫的主要原理。11.肽-hla复合...
MHC; HLA-A*11:01; Peptide Ready表达区间及表达系统(Source) Human Peptide Ready HLA-A*11:01&B2M Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus. It contains Gly25-Thr305(HLA-A*11:01) and Ile21-Met119(B2M).[Accession | AAV53343.1(HLA-A*11:01...